Losartan side effects long term
Searched over 200M research papers
Summary
9 papers analyzed
These studies suggest that long-term use of losartan effectively lowers blood pressure and maintains renal function, but may cause a decrease in hemoglobin, hypotension, and reduced GFR in certain patients.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta19 papers analyzed
Long-Term Side Effects of Losartan
Introduction to Losartan and Its Uses
Losartan is an angiotensin II receptor blocker (ARB) commonly prescribed for managing hypertension, heart failure, and protecting kidney function in patients with diabetes. While it is effective in controlling blood pressure and reducing proteinuria, long-term use of losartan can lead to various side effects that need to be carefully monitored.
Hemodynamic and Renal Effects
Blood Pressure and Renal Function
Long-term administration of losartan has been shown to effectively lower systemic blood pressure and maintain stable graft function in renal transplant recipients. However, a significant reduction in proteinuria was observed, which is beneficial for kidney health. Despite these positive effects, losartan can cause a notable decrease in hemoglobin levels, which may require monitoring and management.
Glomerular Filtration Rate (GFR)
In hypertensive patients, losartan has been associated with an initial acute fall in GFR, which paradoxically predicts a slower decline in long-term renal function. This initial drop in GFR is thought to reflect a hemodynamic effect rather than a detrimental impact on kidney health. Over a longer period, losartan helps in maintaining renal function, although the beneficial effects may attenuate after one year of treatment.
Safety and Tolerability
Common Adverse Events
Clinical trials have reported that losartan is generally well-tolerated, with the most common side effects being headache, upper respiratory tract infection, dizziness, and fatigue. Dizziness was the only side effect that occurred more frequently in losartan-treated groups compared to placebo. Cough, a common side effect of other antihypertensive drugs like ACE inhibitors, was less frequently reported with losartan.
Specific Populations
In patients with heart failure, losartan has shown beneficial hemodynamic effects, such as reduced systemic vascular resistance and pulmonary capillary wedge pressure, without causing significant adverse events. However, in patients with cirrhosis, losartan did not significantly reduce portal pressure and was associated with hypotension and reduced GFR, indicating it may not be suitable for this population .
Long-Term Clinical Outcomes
Marfan Syndrome
In patients with Marfan syndrome, long-term use of losartan, especially when combined with beta-blockers, has shown a reduction in adverse clinical events such as aortic dissection and mortality. This suggests a potential benefit in using losartan for extended periods in this specific patient group.
Conclusion
Losartan is an effective antihypertensive agent with several long-term benefits, including stable renal function and reduced proteinuria. However, it is associated with some side effects such as decreased hemoglobin levels and an initial drop in GFR. While generally well-tolerated, its use in specific populations like those with cirrhosis may require caution. Long-term clinical outcomes in conditions like Marfan syndrome appear promising, indicating the potential for losartan to provide significant benefits beyond blood pressure control. Regular monitoring and individualized patient management are essential to mitigate the risks associated with long-term losartan therapy.
Sources and full results
Most relevant research papers on this topic
